In its statement to USA TODAY, the FDA maintained that, in all post-approvals for food additives, our scientists continue to review relevant new information to determine whether there are safety questions and whether the use of such substance is no longer safe under the Federal Food, Drug, and Cosmetic Act.
The production of Chinese anatase titanium dioxide involves a series of complex chemical processes, including hydrolysis and calcination of titanium precursors. These processes result in the formation of nanoscale particles of anatase titanium dioxide, which exhibit enhanced properties such as increased surface area and improved reactivity. The size and morphology of these nanoparticles can be controlled during the synthesis process, allowing for the production of tailored materials with specific properties for different applications.
The FDA has not updated its general guidance on safety assessments since 2007. Within that time, there has been a significant increase in research on the confluence of toxicology, nanotechnology and human health. The EU updates its guidance regularly with new science available to offer proper safety assessments, with its most recent update published in 2021.